6 results
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - ... cells, triggering insulin ... contraindicated in CKD ... Summary #DM2 #diabetes ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Summary Table Insulin ... modifications Metformin Sulfonylureas ... Improved outcomes in CKD ... comparison #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Classes: Biguanide, Sulfonylurea ... #Mellitus #DM2 ... #Medications #pharmacology ... comparison #table #endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
(stage IV or V CKD ... including most 2 diabetics ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Continue ACEi or ... ml/min per 1.73 m2 ... evidence-based pharmacologic ... #Diabetes #CKD # ... #KDIGO #eGFR #Insulin
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Medications: K+, ACEi ... transfusions), ↓insulin ... (DM, DKA, octreotide ... VBG (acidosis), CK ... Treatments: • Insulin